Gráfico del Precio de Acciones SCNI
SCNI Dividendos
Scinai Immunotherapeutics Ltd
$0.28
-1.71%
$0
Al cierre: Jun 23, 16:00:00 GMT-4
$0.3
4.89%
$0.01
Mercado Posterior: Jun 23, 20:00:00 GMT-4
Atrás
Scinai Immunotherapeutics Ltd (SCNI) Dividendos
Estadísticas clave
Cierre Anterior
$0.291
Precio de apertura
$0.28
Rango del día
$0.2664 - $0.3063
Rango de 52 semanas
$0.3 - $3.48
Volumen
--
Volumen promedio
2.3M
Rendimiento de dividendos
--
EPS (TTM)
-0.00
Cap. de mercado
$1.1M
¿Qué es SCNI?
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Características
© 2026 Edgen impulsado por
